|Positive IF detected in||mouse splenocytes|
|Positive FC detected in||mouse splenocytes|
|Immunofluorescence (IF)||IF : 1:250-1:1000|
|This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results.|
|Sample-dependent, check data in validation data gallery|
CL488-65069 targets CD8a in IF, FC applications and shows reactivity with Mouse samples.
|Host / Isotype||Rat / IgG2a, kappa|
|Immunogen||Spleen cells or thymocyte membranes|
|Full Name||CD8 antigen, alpha chain|
|GenBank accession number||BC030679|
|Gene ID (NCBI)||12525|
|Conjugate||CoraLite® Plus 488 Fluorescent Dye|
|Excitation/Emission maxima wavelengths||493 nm / 522 nm|
|Purification Method||Affinity purification|
|Storage Buffer||PBS with 0.1% sodium azide and 0.5% BSA, pH 7.3.|
|Storage Conditions||Store at 2-8°C. Avoid exposure to light. Stable for one year after shipment.|
CD8 is a transmembrane glycoprotein composed of two disulfide-linked chains. It can be present as a homodimer of CD8α or as a heterodimer of CD8α and CD8β (PMID: 3264320; 8253791). CD8 is found on most thymocytes. The majority of class I-restricted T cells express mostly the CD8αβ heterodimer while CD8αα homodimers alone have been found on some gut intraepithelial T cells , on some T cell receptor (TCR) γδ T cells and on NK cells (PMID: 2111591; 1831127; 8420975). CD8 acts as a co-receptor that binds to MHC class-I and participates in cytotoxic T cell activation (PMID: 8499079). During T cell development, CD8 is required for positive selection of CD4-/CD8+ T cells (PMID: 1968084).
J Immunother Cancer
THADA drives Golgi residency and upregulation of PD-L1 in cancer cells and provides promising target for immunotherapy.
Mol Cell Endocrinol
Melatonin enhances anti-tumor immunity by targeting macrophages PD-L1 via exosomes derived from gastric cancer cells
Activated platelet membrane nanovesicles recruit neutrophils to exert the antitumor efficiency